Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 3
Abstract
Current direct-acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in the treatment failure and relapse. In this paper, we present two cases of hepatitis C in which DAAs failed due to incomplete HCV genotyping.
Authors and Affiliations
Esragül AKINCI, Esra YURDCU, Bahadır ORKUN ÖZBAY, Hürrem BODUR
Keywords
Related Articles
- EP ID EP427190
- DOI 10.4274/vhd.2018.0022
- Views 48
- Downloads 0
Should Hepatitis C Virus Antibody Be Used for Screening Purposes?
Objectives: In this study, hepatitis C virus (HCV) RNA results were retrospectively investigated in patients with reactive HCV antibodies. Materials and Methods: HCV antibody test was performed ELISA method. Enzyme link...
How to Diagnosis the Occult Hepatitis C Virus?
Editorial
Analysis of Virological, Histological and Clinical Features of Hepatitis Delta Virus Infection in Southeastern Turkey
Objectives: The present study aims to investigate biochemical, virological and histological characteristics of hepatitis delta virus infection, which is a serious problem in our region, as well as its relationship with c...
In the Light of European Association for the Study of the Liver 2017: Terminology and Approach to Hepatitis B Virus Reactivation in Patients at High Risk
.
Hepatitis B Virus and Hepatitis C Virus Co-infection: An Evaluation of Eighty-Two Patients
Objective: In this study, we aimed to investigate the characteristics and treatment results of 82 co-infected patients with hepatitis B virus (HBV)/hepatitis C virus (HCV). Materials and Methods: Four university hospita...